CN104042761A - Traditional Chinese medicine (TCM) composition for treating herpes zoster - Google Patents

Traditional Chinese medicine (TCM) composition for treating herpes zoster Download PDF

Info

Publication number
CN104042761A
CN104042761A CN201410322099.7A CN201410322099A CN104042761A CN 104042761 A CN104042761 A CN 104042761A CN 201410322099 A CN201410322099 A CN 201410322099A CN 104042761 A CN104042761 A CN 104042761A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
herpes zoster
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410322099.7A
Other languages
Chinese (zh)
Other versions
CN104042761B (en
Inventor
朱克兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Sanxia Yunhai Pharmaceutical Co., Ltd.
Original Assignee
朱克兰
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 朱克兰 filed Critical 朱克兰
Priority to CN201410322099.7A priority Critical patent/CN104042761B/en
Publication of CN104042761A publication Critical patent/CN104042761A/en
Application granted granted Critical
Publication of CN104042761B publication Critical patent/CN104042761B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine (TCM) composition for treating herpes zoster. The composition is prepared from the following active pharmaceutical ingredients in parts by weight: 13-17 parts of honeysuckle, 13-17 parts of weeping forsythia capsule, 13-17 parts of ocher, 13-17 parts of purslane herb, 13-17 parts of dandelions, 13-17 parts of giant knotweed rhizome, 13-17 parts of amur corktree bark, 13-17 parts of rhubarb root and rhizome, 6-8 parts of baical skullcap root, 6-8 parts of tree peony root bark, 6-8 parts of radix paeoniae rubra, 6-8 parts of cicada slough, 6-8 parts of liquorice, 6-8 parts of Indian bread, 6-8 parts of radix rehmanniae, 2-4 parts of coptis root, 2-4 parts of frankincense and 2-4 parts of myrrh. The composition has the advantages of stable curative effects and no side effects.

Description

A kind of Chinese medicine composition for the treatment of herpes zoster
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of herpes zoster.
Background technology
Herpes zoster is the actute infection dermatoses being caused by varicella zoster virus.After infected without the child of immunity to this virus, there is chickenpox.After some patients were is infected, become carrier and symptom does not occur.Because virus has neurotropism, after infection, can hide for a long time in the neuron of spinal nerves posterior root ganglion, in the time of lower for the resistance or tired, infection, flu, virus can regrow breeding, and move to skin along nerve fiber, make nerve and the skin of being invaded produce strong inflammation.The feature that erythra generally has one-sided property and distributes by nerve segment, is made up of the herpes of collection bunch property, and with pain; Age is larger, and neuralgia is heavier.Primary disease is apt to occur in adult, and season in spring and autumn is common.Sickness rate increased and is remarkable rising with the age.
At present, the medicine for the treatment of herpes zoster is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of herpes zoster, the present invention has advantages of stable curative effect, has no side effect.
Treat a Chinese medicine composition for herpes zoster, made by the crude drug of following weight portion: Flos Lonicerae 13-17 part, Fructus Forsythiae 13-17 part, Haematitum 13-17 part, Herba Portulacae 13-17 part, Herba Taraxaci 13-17 part, Rhizoma Polygoni Cuspidati 13-17 part, Cortex Phellodendri 13-17 part, Radix Et Rhizoma Rhei 13-17 part, Radix Scutellariae 6-8 part, Cortex Moutan 6-8 part, Radix Paeoniae Rubra 6-8 part, Periostracum Cicadae 6-8 part, Radix Glycyrrhizae 6-8 part, Poria 6-8 part, Radix Rehmanniae 6-8 part, Rhizoma Coptidis 2-4 part, Olibanum 2-4 part, Myrrha 2-4 part.
The Chinese medicine composition of described treatment herpes zoster, its preferably: the crude drug by following weight portion is made: 15 parts of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Haematitums, 15 parts of Herba Portulacaes, 15 parts of Herba Taraxacis, 15 parts of Rhizoma Polygoni Cuspidati, 15 parts of Cortex Phellodendris, 15 parts of Radix Et Rhizoma Rhei, 7 parts of Radix Scutellariaes, 7 parts of Cortex Moutans, 7 parts of Radix Paeoniae Rubra, 7 parts of Periostracum Cicadaes, 7 parts, Radix Glycyrrhizae, 7 parts, Poria, 7 parts of Radix Rehmanniae, 3 parts of Rhizoma Coptidis, 3 parts of Olibanums, 3 parts of Myrrhas.
The preparation method of the Chinese medicine composition of described treatment herpes zoster is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment herpes zoster in the banded antiherpetic thing of preparation treatment.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, choose each crude drug and proportioning thereof, there is the function of Clearing fire of heart and liver, clearing away heat and cooling blood, removing toxic substances, dampness removing heat, realize the object for the treatment of herpes zoster.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats Patients with Herpes Zoster 54 examples altogether, wherein, male 25 examples, female's 29 examples, the age is 22-55 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., taking decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 5 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: deflorescence, clinical sign disappears, without pain sequela.
Take a turn for the better: deflorescence approximately 30%, pain obviously alleviates.
Do not heal: deflorescence less than 30%, still has pain.
(4) therapeutic outcome: the present invention treats Patients with Herpes Zoster 54 examples altogether, through 1-2 course of therapy, cures 46 examples, accounts for 85.2%, and 4 examples that take a turn for the better, account for 7.4%, and 4 examples that do not heal, account for 7.4%, and effective percentage is 92.6%, has no any side effect; Cure in 46 examples, cure 19 examples 1 course for the treatment of, cure 27 examples 2 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, sternly certain, female, 31 years old, unbearably, there is the several groups of pimples in blocks, blister in the scorching hot twinge of three days front left ribbed hide skins, pruritus, is zonal distribution two days later on it, substrate is around with blush, twinge unbearably, uneasy in either sitting or lying.Companion's low grade fever, aversion to cold, weak, inappetence.Take Chinese medicine composition of the present invention and cure 1 course for the treatment of, after half a year, follow up a case by regular visits to, not recurrence.
2, year so-and-so, man, 25 years old, herpes zoster facialis, sick rising 5 days.Right flank lip has large phlysis as the Semen phaseoli radiati of cluster, and bleb week substrate is rubescent, and it is transparent that bleb liquid has, and some muddinesses have jumping pain, twinge, pruritus; Conjunctiva of right eye hyperemia, right side submandibular lymph nodes enlargement.Take Chinese medicine composition of the present invention and cure 2 courses for the treatment of, after half a year, follow up a case by regular visits to, not recurrence.
3, Xu so-and-so, female, 55 years old, erubescence, had blister, tonic vesicle wall, scorching hot twinge forms red chestnut, bitter taste in the mouth and dry throat is thirsty, irritated irritability, oliguria with reddish urine, constipation with dry stool.After taking 2 courses for the treatment of of Chinese medicine composition of the present invention, cure, after half a year, follow up a case by regular visits to, not recurrence.
Detailed description of the invention
Embodiment 1:
Treat a Chinese medicine composition for herpes zoster, made by the crude drug of following weight portion: 13 parts of Flos Loniceraes, 13 parts of Fructus Forsythiaes, 13 parts of Haematitums, 13 parts of Herba Portulacaes, 13 parts of Herba Taraxacis, 13 parts of Rhizoma Polygoni Cuspidati, 13 parts of Cortex Phellodendris, 13 parts of Radix Et Rhizoma Rhei, 6 parts of Radix Scutellariaes, 6 parts of Cortex Moutans, 6 parts of Radix Paeoniae Rubra, 6 parts of Periostracum Cicadaes, 6 parts, Radix Glycyrrhizae, 6 parts, Poria, 6 parts of Radix Rehmanniae, 2 parts of Rhizoma Coptidis, 2 parts of Olibanums, 2 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for herpes zoster, made by the crude drug of following weight portion: 15 parts of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Haematitums, 15 parts of Herba Portulacaes, 15 parts of Herba Taraxacis, 15 parts of Rhizoma Polygoni Cuspidati, 15 parts of Cortex Phellodendris, 15 parts of Radix Et Rhizoma Rhei, 7 parts of Radix Scutellariaes, 7 parts of Cortex Moutans, 7 parts of Radix Paeoniae Rubra, 7 parts of Periostracum Cicadaes, 7 parts, Radix Glycyrrhizae, 7 parts, Poria, 7 parts of Radix Rehmanniae, 3 parts of Rhizoma Coptidis, 3 parts of Olibanums, 3 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for herpes zoster, made by the crude drug of following weight portion: 17 parts of Flos Loniceraes, 17 parts of Fructus Forsythiaes, 17 parts of Haematitums, 17 parts of Herba Portulacaes, 17 parts of Herba Taraxacis, 17 parts of Rhizoma Polygoni Cuspidati, 17 parts of Cortex Phellodendris, 17 parts of Radix Et Rhizoma Rhei, 8 parts of Radix Scutellariaes, 8 parts of Cortex Moutans, 8 parts of Radix Paeoniae Rubra, 8 parts of Periostracum Cicadaes, 8 parts, Radix Glycyrrhizae, 8 parts, Poria, 8 parts of Radix Rehmanniae, 4 parts of Rhizoma Coptidis, 4 parts of Olibanums, 4 parts of Myrrhas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.

Claims (4)

1. a Chinese medicine composition for the treatment of herpes zoster, is characterized in that: the crude drug by following weight portion is made: Flos Lonicerae 13-17 part, Fructus Forsythiae 13-17 part, Haematitum 13-17 part, Herba Portulacae 13-17 part, Herba Taraxaci 13-17 part, Rhizoma Polygoni Cuspidati 13-17 part, Cortex Phellodendri 13-17 part, Radix Et Rhizoma Rhei 13-17 part, Radix Scutellariae 6-8 part, Cortex Moutan 6-8 part, Radix Paeoniae Rubra 6-8 part, Periostracum Cicadae 6-8 part, Radix Glycyrrhizae 6-8 part, Poria 6-8 part, Radix Rehmanniae 6-8 part, Rhizoma Coptidis 2-4 part, Olibanum 2-4 part, Myrrha 2-4 part.
2. the Chinese medicine composition for the treatment of herpes zoster according to claim 1, is characterized in that: the crude drug by following weight portion is made: 15 parts of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Haematitums, 15 parts of Herba Portulacaes, 15 parts of Herba Taraxacis, 15 parts of Rhizoma Polygoni Cuspidati, 15 parts of Cortex Phellodendris, 15 parts of Radix Et Rhizoma Rhei, 7 parts of Radix Scutellariaes, 7 parts of Cortex Moutans, 7 parts of Radix Paeoniae Rubra, 7 parts of Periostracum Cicadaes, 7 parts, Radix Glycyrrhizae, 7 parts, Poria, 7 parts of Radix Rehmanniae, 3 parts of Rhizoma Coptidis, 3 parts of Olibanums, 3 parts of Myrrhas.
3. the preparation method of the Chinese medicine composition for the treatment of herpes zoster according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of herpes zoster according to claim 1 and 2 in the banded antiherpetic thing of preparation treatment.
CN201410322099.7A 2014-07-05 2014-07-05 A kind of Chinese medicine composition for the treatment of herpes zoster Active CN104042761B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410322099.7A CN104042761B (en) 2014-07-05 2014-07-05 A kind of Chinese medicine composition for the treatment of herpes zoster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410322099.7A CN104042761B (en) 2014-07-05 2014-07-05 A kind of Chinese medicine composition for the treatment of herpes zoster

Publications (2)

Publication Number Publication Date
CN104042761A true CN104042761A (en) 2014-09-17
CN104042761B CN104042761B (en) 2016-05-18

Family

ID=51496484

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410322099.7A Active CN104042761B (en) 2014-07-05 2014-07-05 A kind of Chinese medicine composition for the treatment of herpes zoster

Country Status (1)

Country Link
CN (1) CN104042761B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104491550A (en) * 2014-12-31 2015-04-08 冯凤 Traditional Chinese medicine paste for treating crystalli and preparation method thereof
CN105031199A (en) * 2015-09-07 2015-11-11 王俊喜 Traditional Chinese medicine for treating herpes zoster
CN105288162A (en) * 2015-11-27 2016-02-03 陈如燕 Traditional Chinese medicine preparation for inhibiting herpes virus
CN106421289A (en) * 2016-10-28 2017-02-22 广西大学 Unguent for treating herpes zoster and preparing method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038853A (en) * 2009-10-20 2011-05-04 焦趁英 Externally applied plaster for treating herpes zoster
CN103585524A (en) * 2013-10-07 2014-02-19 李智锋 Traditional Chinese medicament preparation for treating various types of skin diseases caused by dampness, heat, dry blood and unsmooth venation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038853A (en) * 2009-10-20 2011-05-04 焦趁英 Externally applied plaster for treating herpes zoster
CN103585524A (en) * 2013-10-07 2014-02-19 李智锋 Traditional Chinese medicament preparation for treating various types of skin diseases caused by dampness, heat, dry blood and unsmooth venation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104491550A (en) * 2014-12-31 2015-04-08 冯凤 Traditional Chinese medicine paste for treating crystalli and preparation method thereof
CN104491550B (en) * 2014-12-31 2018-01-16 冯凤 A kind of Chinese medicinal ointment for treating varicella and preparation method thereof
CN105031199A (en) * 2015-09-07 2015-11-11 王俊喜 Traditional Chinese medicine for treating herpes zoster
CN105288162A (en) * 2015-11-27 2016-02-03 陈如燕 Traditional Chinese medicine preparation for inhibiting herpes virus
CN106421289A (en) * 2016-10-28 2017-02-22 广西大学 Unguent for treating herpes zoster and preparing method thereof

Also Published As

Publication number Publication date
CN104042761B (en) 2016-05-18

Similar Documents

Publication Publication Date Title
CN103800485A (en) Traditional Chinese medicine preparation for treating herpes simplex keratitis
CN101966320A (en) Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof
CN103316174B (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN102697903A (en) Medicine for treating herpes zoster
CN104042761A (en) Traditional Chinese medicine (TCM) composition for treating herpes zoster
CN102363020B (en) Chinese medicinal composition for treating proliferation of mammary gland
CN102430071B (en) Medicament for treating herpes zoster
CN104547666A (en) Traditional Chinese medicine composition for treating herpes zoster
CN103432545A (en) Medicament for allaying fever of child and preparation method thereof
CN103705782A (en) Traditional Chinese medicine composition for treating herpes zoster
CN102512617B (en) Chinese herbal preparation for treating psoriasis
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN104288328B (en) A kind of Chinese medicine composition treating herpes zoster and preparation method thereof
CN103356969A (en) Traditional Chinese medicine composition for treating hysteromyoma
CN103341037B (en) Traditional Chinese medicine composition for treating azoospermia
CN103908556A (en) Traditional Chinese medicine for treating varicella
CN102716336B (en) External use ointment for treating herpes zoster
CN103893502A (en) Traditional Chinese medicine for treating phlyctenular conjunctivitis
CN104056177A (en) Traditional Chinese medicine composition for treating otitis media
CN104027514A (en) Traditional Chinese medicine used for treating acute cholecystitis
CN103736047A (en) Chinese herbal medicine formula for dispelling cold and preparation method thereof
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN103191230B (en) Traditional Chinese medicine for treating infantile recurrent hordeolum
CN103830510A (en) Traditional Chinese medicine preparation for treating infantile eczema

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20160422

Address after: 233300 Anhui city of Bengbu province Wuhe County head Pu Zhen Agricultural Science and Technology Park

Applicant after: Prosperous luxuriant kind cultivation farmer specialized cooperative society, Wuhe County

Address before: 233000 Anhui Province, Bengbu City Economic Development Zone Jingshan Road No. 558 Building 1 unit 9 jinau Washington District 501 room

Applicant before: Zhu Kelan

C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Wang Fangfang

Inventor before: Zhu Kelan

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20170831

Address after: 300000, Nankai District, Tianjin Ocean Road, No. 2, building 6, 501

Patentee after: Wang Fangfang

Address before: 233300 Anhui city of Bengbu province Wuhe County head Pu Zhen Agricultural Science and Technology Park

Patentee before: Prosperous luxuriant kind cultivation farmer specialized cooperative society, Wuhe County

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20181116

Address after: 404500 Yunyang County Industrial Park, Chongqing

Patentee after: Chongqing Sanxia Yunhai Pharmaceutical Co., Ltd.

Address before: 300000 Haidao Lianxin Building 6 Gate 501, Nankai District, Tianjin

Patentee before: Wang Fangfang

TR01 Transfer of patent right